Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Sellas Life Sciences Group

Clinical trials sponsored by Sellas Life Sciences Group, explained in plain language.

Trials to join now! 2 Not yet finished but already full! 1

New shot aims to keep AML in check after tough second-line therapy

Disease control Ongoing

This study tests an experimental immune-boosting shot called Galinpepimut-S (GPS) in adults with acute myeloid leukemia (AML) who are in remission after second-line salvage therapy. Participants receive either GPS or the doctor's choice of standard treatments. The goal is to see …

Phase: PHASE3 • Sponsor: Sellas Life Sciences Group • Aim: Disease control

Last updated Apr 28, 2026 23:51 UTC